Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In Vivo
Authors:
Open Access
- 1 September 2012
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 20 (9) , 1676-1688
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses CollideMolecular Therapy, 2011
- Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cellsJournal of Clinical Investigation, 2011
- Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine VectorsJournal of Virology, 2011
- A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic DiseasesClinical Cancer Research, 2010
- Arginine Methylation of Human Adenovirus Type 5 L4 100-Kilodalton Protein Is Required for Efficient Virus ProductionJournal of Virology, 2009
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossLaboratory Investigation, 2009
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Presence of the Adenovirus IVa2 Protein at a Single Vertex of the Mature VirionJournal of Virology, 2008
- Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancerOncogene, 2007